Maija Itälä-Remes
MD, PhD, Adjunct professor

Adjunct Professor, Department of Clinical Medicine (Department of Clinical Medicine)

Areas of expertise
Haematology; Acute Leukemia; Haematopoietic Stem Cell Transplantation


Academic degrees:

Medical doctor 26.5.1986, University of Turku, Finland
Doctoral thesis (”B-cell Chronic Lymphocytic Leukemia and Increased Susceptibility to Infections”) and 13.9.1996, University of Turku
Doctorate, PhD 4.12.1997, University of Turku
Adjunct professor Internal Medicine/Clinical Haematology 18.4.2005, University of Turku

Professional appointments:

Resident/specialist in Internal Medicine and in Anaesthesia 1986-1997 Turku University Central Hospital.
Clinical haematologist, Turku University Central Hospital 1997-2007.
Medical Adviser, Janssen-Cilag, Nordic Section 2007-2008.  
Head of Department of Haematology, Tampere University Central Hospital 2008-2010.
Head of Stem Cell Transplant Unit, Turku University Hospital 2010-2017.
Head of Stem Cell Transplant Unit, Helsinki University Hospital 2017-2018.
Head of Division of Clinical Haematology and Stem Cell Transplant Unit, Programme Director of Stem Cell Transplant Unit, Turku University Central Hospital 2018-


Supervisor 3, Opponent 2, Reviewer 4

Other academic appontments:

Review of the scientific work for docent application

Appointments in Scientific Societies:

Chair of the Finnish Society of Haematology 2012-2014, member 2014-.
Chair of the Finnish Acute Leukemia Working Group 2015-2018, member 2018-
The Nordic-Dutch Working Group for CLL (Chronic Lymphocytic Leukemia) Group, member 2000-2014.
The Finnish Haematology Registry and Biobank, member of the Steering group 2012-2014.
The European Group for Blood and Marrow Transplantation, member 1997-

Duties with National Authorities:

Consultant of the Parliament (Implementation of EU directives into National legislation) 2006-2007
Consultant of the Ministry of Social Affairs and Health (STM) 2016
Consultant of the Finnish Medicine Agency (Fimea) 2016-2018
EU consultation Brussels 2017

Activities in Quality Management:

Inspector exam of FACT/JACIE Quality Management System 31.5.2011, Rotterdam.
Establishment of the Quality Management System of the Stem Cell Unit of Turku University Hospital 2006; Moderation of initial JACIE accreditation and two re-accreditations 2006-2017 Turku University Central Hospital, Turku.


Scientific publications and text book articles in field of stem cell transplantions and haematological malignancies

Principal Investigator and Sub-investigator of International Multicentre Clinical Trials

GCP training, latest update 22.2.2018


Lectures at Finnish University Hospitals and Central Hospitals

Public lectures

Lectures at International meetings

Education of residents and junior colleagues (Clinical haematology and Stem Cell Transplantations)

Member of Faculty of the International Congress on Stem Cell Transplantation and Cellular Therapies, Berlin 2017

Go to first page Go to previous page 1 of 2 Go to next page Go to last page

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation (2019)
J. Ritari, K. Hyvärinen, S. Koskela, M. Itälä-Remes, R. Niittyvuopio, A. Nihtinen, U. Salmenniemi, M. Putkonen, L. Volin, T. Kwan, T. Pastinen, J. Partanen
A1 Journal article – refereed)

Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant (2019)
Biology of Blood and Marrow Transplantation
Maura Faraci, Tamara Diesch, Myriam Labopin, Arnaud Dalissier, Arian Lankester, Andrew Gennery, Mikael Sundin, Duygu Uckan-Cetinkaya, Marc Bierings, Anke M.J. Peters, Martina Garwer, Ansgar Schulz, Gerard Michel, Giovanna Giorgiani, Bernd Gruhn, Franco Locatelli, Stefano Giardino, Anne Uyttebroeck, Fanny Rialland, Maija Itäla-Remes, Peter Dreger, Peter J. Shaw, Victoria Bordon, Paul G. Schlegel, Karin Mellgren, Jose M. Moraleda, Katharine Patrick, Pascale Schneider, Charlotte Jubert, Anita Lawitschka, Nina Salooja, Grzegorz W. Basak, Selim Corbaciuoglu, Rafael Duarte, Peter Bader
A1 Journal article – refereed)

Raudanpuute ilman anemiaa - miten ferritiiniarvoa tulkitaan? (2019)
Ebeling Freja, Sinisalo Marjatta, Säily Marjaana, Widenius Tom, Kuittinen Taru, Itälä-Remes Maija, Remes Kari
D1 Article in a trade journal)

Allogeeniset kantasolusiirrot soveltuvat iäkkäillekin (2018)
Jokela S, Itälä-Remes M, Salmenniemi U, Putkonen M, Kauppila M, Salmi T, Salomäki S, Remes K
A1 Journal article – refereed)

Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT (2018)
Czerw T, Labopin M, Giebel S, Socie G, Volin L, Fegueux N, Masszi T, Blaise D, Chaganti S, Cornelissen JJ, Passweg J, Maertens J, Itala-Remes M, Wu D, Mohty M, Nagler A
A1 Journal article – refereed)

Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT (2018)
American Journal of Hematology
Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itälä-Remes M, Chevallier P, Labussiére-Wallet H, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A
A1 Journal article – refereed)

Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT (2018)
Juha Ranti, Samu Kurki, Urpu Salmenniemi, Mervi Putkonen, Soile Salomäki, Maija Itälä-Remes
A1 Journal article – refereed)

Hidden genomic MHC disparity between HLA-amtched sibling pairs in hematopoietic stem cell transplantation (2018)
Scientific Reports
Koskela S, Ritari J, Hyvärinen K, Kwan T, Niittyvuopio R, Itälä-Remes M, Pastinen T, Partanen J.
A1 Journal article – refereed)

Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety (2018)
Molecular therapy. Methods & clinical development
Joni Keto, Tanja Kaartinen, Urpu Salmenniemi, Johanna Castrén, Jukka Partanen, Arno Hänninen, Matti Korhonen, Kaarina Lähteenmäki, Maija Itälä-Remes, Johanna Nystedt
A1 Journal article – refereed)

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT (2018)
Nico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, Linda Koster, Hareth Nahi, Anne-Marie Stoppa, Tamás Masszi, Denis Caillot, Stig Lenhoff, Miklos Udvardy, Charles Crawley, William Arcese, Clara Mariette, Ann Hunter, Xavier Leleu, Martin Schipperus, Michel Delforge, Pietro Pioltelli, John A. Snowden, Maija Itälä-Remes, Maurizio Musso, Anja van Biezen, Laurent Garderet, Nicolaus Kröger
A1 Journal article – refereed)

Increased MHC matching by C4 gene compatibility in URD HSCT (2018)
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation Jonna Clancy, Jarmo Ritari, Muriel Lobier, Riitta Niittyvuopio, Urpu Salmenniemi, Mervi Putkonen, Maija Itälä-Remes, Jukka Partanen, Satu Koskela
A1 Journal article – refereed)

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT (2018)
British Journal of Haematology
Donal P. McLornan, Richard Szydlo, Marie Robin, Anja van Biezen, Linda Koster, Henrik J. P. Blok, Maria T. Van Lint, Jürgen Finke, Antonin Vitek, Kristina Carlson, Laimonas Griskevicius, Ernst Holler, Maija Itälä-Remes, Michel Schaap, Gerard Socié, Jacques-Olivier Bay, Yves Beguin, Benedetto Bruno, Jan J. Cornelissen, Tobias Gedde-Dahl, Per Ljungman, Marie T. Rubio, Ibrahim Yakoub-Agha, Evgeny Klyuchnikov, Eduardo Olavarria, Yves Chalandon, Nicolaus Kröger
A2 Review article in a scientific journal)

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT (2018)
Journal of Hematology and Oncology
Annalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, Boris Afanasyev, Jan J. Cornelissen, Ahmet Elmaagacli, Maija Itälä-Remes, Didier Blaise, Ellen Meijer, Yener Koc, Noel Milpied, Harry C. Schouten, Nicolaus Kroeger, Mohamad Mohty, Arnon Nagler
A1 Journal article – refereed)

Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study (2017)
Infectious Diseases
Kolonen A, Sinisalo M, Huttunen R, Syrjanen J, Aittoniemi J, Huhtala H, Sankelo M, Rintala H, Raty R, Jantunen E, Nousiainen T, Saily M, Kauppila M, Itala-Remes M, Ollikainen H, Rauhala A, Koistinen P, Elonen E
A1 Journal article – refereed)

Good responses but high TRM in adult patients after MSC therapy for GvHD (2017)
Bone Marrow Transplantation
Salmenniemi U, Itälä-Remes M, Nystedt J, Putkonen M, Niittyvuopio R, Vettenranta K, Korhonen M
B1 Journal article)

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (2017)
Journal of Clinical Oncology
Martinez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, Castagna L, Afanasyev B, Robinson S, Blaise D, Corradini P, Itala-Remes M, Bermudez A, Forcade E, Russo D, Potter M, McQuaker G, Yakoub-Agha I, Scheid C, Bloor A, Montoto S, Dreger P, Sureda A
A1 Journal article – refereed)

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia (2017)
Leukemia and Lymphoma
Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van t' Veer MB, Tjonnfjord GE, Itala-Remesg MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, Van Oers MHJ, Geisler CH, Niemann CU
A1 Journal article – refereed)

The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia (2017)
Leukemia and Lymphoma
Vojdeman FJ, van't Veer MB, Tjonnfjord GE, Itala-Remes M, Kimby E, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH
A1 Journal article – refereed)

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party (2017)
Bone Marrow Transplantation
Scheid C, de Wreede L, van Biezen A, Koenecke C, Gohring G, Volin L, Maertens J, Finke J, Passweg J, Beelen D, Cornelissen JJ, Itala-Remes M, Chevallier P, Russell N, Petersen E, Milpied N, Espiga CR, Peniket A, Sierra J, Mufti G, Crawley C, Veelken JH, Ljungman P, Cahn JY, Alessandrino EP, de Witte T, Robin M, Kroger N
A1 Journal article – refereed)

A Prospective Randomized Trial Comparing Cyclosporine/Methotrexate And Tacrolimus/Sirolimus As Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation (2016)
Törlén J, Ringdén O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, Itälä-Remes M, Remberger M, Mattsson J
A1 Journal article – refereed)

Last updated on 2018-03-11 at 01:19